cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLC10.15829/1728-8800-2017-5-76-80cardiovascular-647Research ArticleМНЕНИЕ ПО ПРОБЛЕМЕOPINION ON A PROBLEMКОМОРБИДНЫЙ ПАЦИЕНТ В КЛИНИКЕ ВНУТРЕННИХ БОЛЕЗНЕЙ: СЕРДЕЧНО-СОСУДИСТЫЕ ЗАБОЛЕВАНИЯ И ТРЕВОГАCOMORBID PATIENT IN THE INTERNAL MEDICINE: CARDIOVASCULAR DISEASES AND ANXIETYСеливановаГ. Б.SelivanovaG. B.

д.м.н., профессор, профессор кафедры общей терапии ФДПО,

Москва

Moscow

galina.selivanova@rambler.ruФГБОУ ВО Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздрава РоссииN.I. Pirogov Russian National Research Medical University (RNRMU)2017201020171657680Copyright © Селиванова Г.Б., 20172017Селиванова Г.Б.Selivanova G.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/647

Высокая распространенность тревожно-депрессивных расстройств и неуклонный рост сердечно-сосудистых заболеваний делает актуальной проблему своевременной диагностики и дифференцированной фармакотерапии коморбидных пациентов в клинике внутренних болезней. В статье представлены новые данные о взаимосвязи нарушений психоэмоциональной сферы и риска сердечно-сосудистых событий, а также проанализированы проблемы фармакотерапии. На основе представленных данных делается заключение о необходимости разработки тактики ведения таких пациентов.

High prevalence of anxiety and depression disorders, as the increase of cardiovascular pathology prevalence make the problem of on time diagnostics and correction actual and important, as of the differential pharmacotherapy in internal disease practice. The article points on the data of relations in psychoemotional disorders and cardiovascular risks, as on the issues of pharmacotherapy. Based on the data presented, the conclusion done on the necessity of a specific tactics of such patients management.

тревогадепрессияартериальная гипертензияишемическая болезнь сердцаanxietydepressionarterial hypertensionischemic heart diseaseReferenceshttp://www.who.int/mediacentre/news/releases/2016/depression-anxietytreatment/ru (13 Apr 2016)http://www.who.int/mediacentre/news/releases/2016/depression-anxietytreatment/ru (13 Apr 2016)http://www.who.int/mediacentre/factsheets/fs369/ru (Feb 2017 )http://www.who.int/mediacentre/factsheets/fs369/ru (Feb 2017 )http://www.who.int/mediacentre/factsheets/fs396/ru/ (Apr 2017)http://www.who.int/mediacentre/factsheets/fs396/ru/ (Apr 2017)Liu MY, Li N, Li WA, et al. Association between psychosocial stress and hypertension: a systematic review and meta-analysis. Neurol Res 2017; Jun; 39 (6): 573-80.Liu MY, Li N, Li WA, et al. Association between psychosocial stress and hypertension: a systematic review and meta-analysis. Neurol Res 2017; Jun; 39 (6): 573-80.Fedotova AV. Anxiety-depressive disorders in general clinical practice. Rational pharmacotherapy in cardiology 2008; 3: 83-7. Russian (Федотова А.В. Тревожнодепрессивные расстройства в общеклинической практике. Рациональная фармакотерапия в кардиологии 2008; 3: 83-7).Fedotova AV. Anxiety-depressive disorders in general clinical practice. Rational pharmacotherapy in cardiology 2008; 3: 83-7. Russian (Федотова А.В. Тревожнодепрессивные расстройства в общеклинической практике. Рациональная фармакотерапия в кардиологии 2008; 3: 83-7).Pogosova GV. Psychoemotional disorders in patients with cardiovascular diseases: treatment issues. Cardovascular Therapy and Prevention 2006; 5 (2): 94-9. Russian (Погосова Г.В. Психоэмоциональные расстройства у больных сердечно-сосудистыми заболеваниями: вопросы лечения. Кардоваскулярная терапия и профилактика 2006; 5 (2): 94-9).Pogosova GV. Psychoemotional disorders in patients with cardiovascular diseases: treatment issues. Cardovascular Therapy and Prevention 2006; 5 (2): 94-9. Russian (Погосова Г.В. Психоэмоциональные расстройства у больных сердечно-сосудистыми заболеваниями: вопросы лечения. Кардоваскулярная терапия и профилактика 2006; 5 (2): 94-9).http://www.who.int/mediacentre/factsheets/fs317/ru/ (Jan 2015)http://www.who.int/mediacentre/factsheets/fs317/ru/ (Jan 2015)http://www.who.int/cardiovascular_diseases/about_cvd/ru/http://www.who.int/cardiovascular_diseases/about_cvd/ru/Soloveva SL, Uspenskyi UP, Balukova EV. Depression in the therapeutic clinic (pathopsychological, psychotherapeutic and psychopharmacological aspects). SPb.: InfomMed, 2008; 204 р. Russian (Соловьева С. Л., Успенский Ю. П., Балукова Е.В. Депрессия в терапевтический клинике (патопсихологические, психотерапевтические и психофармакологические аспекты). СПб.: ИнформМед 2008; 204 с.).Soloveva SL, Uspenskyi UP, Balukova EV. Depression in the therapeutic clinic (pathopsychological, psychotherapeutic and psychopharmacological aspects). SPb.: InfomMed, 2008; 204 р. Russian (Соловьева С. Л., Успенский Ю. П., Балукова Е.В. Депрессия в терапевтический клинике (патопсихологические, психотерапевтические и психофармакологические аспекты). СПб.: ИнформМед 2008; 204 с.).Medvedev VE. Therapy of anxiety disorders in patients with cardiovascular diseases (experience with afobazole). Archive of internal medicine 2013; 3 (11): 70-6. Russian (Медведев В.Э. Терапия тревожных расстройств у пациентов с сердечно-сосудистыми заболеваниями (опыт применения афобазола). Архив внутренней медицины 2013; 3 (11): 70-6).Medvedev VE. Therapy of anxiety disorders in patients with cardiovascular diseases (experience with afobazole). Archive of internal medicine 2013; 3 (11): 70-6. Russian (Медведев В.Э. Терапия тревожных расстройств у пациентов с сердечно-сосудистыми заболеваниями (опыт применения афобазола). Архив внутренней медицины 2013; 3 (11): 70-6).Yasunari K, Matsui T, Maeda K, et al. Anxiety-induced plasma norepinephrine augmentation increases reactive oxygen species formation by monocytes in essential hypertension. Am J Hypertens 2006; 19: 573-8.Yasunari K, Matsui T, Maeda K, et al. Anxiety-induced plasma norepinephrine augmentation increases reactive oxygen species formation by monocytes in essential hypertension. Am J Hypertens 2006; 19: 573-8.Ozdoeva LD, Nebieridze DV, Pogosova GV, et al. Interrelation of risk factors of atherosclerosis and anxiety-depressive states in men from an unorganized population. Cardiovascular Therapy and Prevention 2003; 2 (1): 59-64. Russian (Оздоева Л.Д., Небиеридзе Д.В., Погосова Г.В. и др. Взаимосвязь факторов риска атеросклероза и тревожно-депрессивных состояний у мужчин из неорганизованной популяции. Кардиоваскулярная терапия и профилактика 2003; 2 (1): 59-64).Ozdoeva LD, Nebieridze DV, Pogosova GV, et al. Interrelation of risk factors of atherosclerosis and anxiety-depressive states in men from an unorganized population. Cardiovascular Therapy and Prevention 2003; 2 (1): 59-64. Russian (Оздоева Л.Д., Небиеридзе Д.В., Погосова Г.В. и др. Взаимосвязь факторов риска атеросклероза и тревожно-депрессивных состояний у мужчин из неорганизованной популяции. Кардиоваскулярная терапия и профилактика 2003; 2 (1): 59-64).Piccirillo G, Viola E, Nocco M, et al. Autonomic modulation and QT interval dispersion in hypertensive subjects with anxiety. Hypertension 1999; 34: 242-6.Piccirillo G, Viola E, Nocco M, et al. Autonomic modulation and QT interval dispersion in hypertensive subjects with anxiety. Hypertension 1999; 34: 242-6.Krichenko AA. Depression, anxiety and cardiovascular system. Lechashij vrach 2012; 2. Russian (Криченко A.A. Депрессия, беспокойство и сердечно-сосудистая система. Лечащий врач 2012; 2).Krichenko AA. Depression, anxiety and cardiovascular system. Lechashij vrach 2012; 2. Russian (Криченко A.A. Депрессия, беспокойство и сердечно-сосудистая система. Лечащий врач 2012; 2).Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep 2013; 15: 134-6.Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep 2013; 15: 134-6.Wilkins K, Campbell NR, Joffres MR, et al. Blood pressure in Canadianadults. Health Rep 2010; 21: 37-46.Wilkins K, Campbell NR, Joffres MR, et al. Blood pressure in Canadianadults. Health Rep 2010; 21: 37-46.Roest AM, Martens EJ, de Jonge P, et al. Anxiety and risk of incident coronary heart disease: a meta-analysis. JACC 2010; 56: 38-46.Roest AM, Martens EJ, de Jonge P, et al. Anxiety and risk of incident coronary heart disease: a meta-analysis. JACC 2010; 56: 38-46.Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: ameta-analysis of 6362 events among 146538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-74.Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: ameta-analysis of 6362 events among 146538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-74.Mehmet EÖ, Ebru Ö, Nazile BD, et al. Impact of anxiety level on circadian rhythm of blood pressure in hypertensive patients. J Clin Exp Med 2015; 8 (9): 16252-8.Mehmet EÖ, Ebru Ö, Nazile BD, et al. Impact of anxiety level on circadian rhythm of blood pressure in hypertensive patients. J Clin Exp Med 2015; 8 (9): 16252-8.Tsartsalis D, Dragioti E, Kontoangelos K, et al. The impact of depression and cardiophobia on quality of life in patients with essential hypertension. Psychiatriki 2016 Jul-Sep; 27 (3): 192-203.Tsartsalis D, Dragioti E, Kontoangelos K, et al. The impact of depression and cardiophobia on quality of life in patients with essential hypertension. Psychiatriki 2016 Jul-Sep; 27 (3): 192-203.Sandström YK, Ljunggren G, Wändell P, et al. Psychiatric comorbidities in patients with hypertension - a study of registered diagnoses 2009-2013 in the total population in Stockholm County, Sweden. J Hypertens 2016; 34 (3): 414-20.Sandström YK, Ljunggren G, Wändell P, et al. Psychiatric comorbidities in patients with hypertension - a study of registered diagnoses 2009-2013 in the total population in Stockholm County, Sweden. J Hypertens 2016; 34 (3): 414-20.Jackson CA, Pathirana T, Gardiner PA. Depression, anxiety and risk of hypertension in mid-aged women: a prospective longitudinal study. J Hypertens 2016; 34 (10): 1959-66.Jackson CA, Pathirana T, Gardiner PA. Depression, anxiety and risk of hypertension in mid-aged women: a prospective longitudinal study. J Hypertens 2016; 34 (10): 1959-66.Maatouk I, Herzog W, Böhlen F, et al. Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults. J Hypertens 2016; 34 (9): 1711-20.Maatouk I, Herzog W, Böhlen F, et al. Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults. J Hypertens 2016; 34 (9): 1711-20.Bulgakov MS, Avtandilova AG, Milovanova OA. The role of long-term stress and the functional state of the endothelium in the development of the syndrome of vegetative dystonia. J Neur and psych 2015; 9: 4-7. Russian (Булгаков М.С., Автандилова А.Г., Милованова О.А. Роль длительного стресса и функционального состояния эндотелия в развитии синдрома вегетативной дистонии. Журнал невр и псих 2015; 9: 4-7).Bulgakov MS, Avtandilova AG, Milovanova OA. The role of long-term stress and the functional state of the endothelium in the development of the syndrome of vegetative dystonia. J Neur and psych 2015; 9: 4-7. Russian (Булгаков М.С., Автандилова А.Г., Милованова О.А. Роль длительного стресса и функционального состояния эндотелия в развитии синдрома вегетативной дистонии. Журнал невр и псих 2015; 9: 4-7).Bhat SK, Beilin LJ, Robinson M, et al. Relationships between depression and anxiety symptoms scores and blood pressure in young adults. J Hypertens 2017; May: 12-7.Bhat SK, Beilin LJ, Robinson M, et al. Relationships between depression and anxiety symptoms scores and blood pressure in young adults. J Hypertens 2017; May: 12-7.Khatib R, Schwalm JD, Yusuf S, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and metaanalysis of qualitative and quantitative studies. PLoS One 2014; 9: e84238.Khatib R, Schwalm JD, Yusuf S, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and metaanalysis of qualitative and quantitative studies. PLoS One 2014; 9: e84238.García-Ortiz L, Gómez-Marcos MA, Martín-Moreiras J, et al. Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organ damage in hypertensive patients (LOD-RISK study). Blood Press Monit 2009; 14: 145-51.García-Ortiz L, Gómez-Marcos MA, Martín-Moreiras J, et al. Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organ damage in hypertensive patients (LOD-RISK study). Blood Press Monit 2009; 14: 145-51.Verdecchia P, Angeli F, Mazzotta G, et al. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension 2012; 60: 34-42.Verdecchia P, Angeli F, Mazzotta G, et al. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension 2012; 60: 34-42.Kikuya M, Hozava A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate varisbilities: the Ohasama Study. Hypertension 2000; 36: 901-6.Kikuya M, Hozava A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate varisbilities: the Ohasama Study. Hypertension 2000; 36: 901-6.Sega R, Corrao G, Bombelli M, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA Study. Hypertension 2002; 39: 710-4.Sega R, Corrao G, Bombelli M, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA Study. Hypertension 2002; 39: 710-4.Tully PJ, Tzourio C . Psychiatric correlates of blood pressure variability in the elderly: The Three City cohort study. Physiol Behav 2017; 168: 91-7.Tully PJ, Tzourio C . Psychiatric correlates of blood pressure variability in the elderly: The Three City cohort study. Physiol Behav 2017; 168: 91-7.Gustad LT, Bjerkeset O, Strand LB, et al. Cardiac function associated with previous, current and repeated depression and anxiety symptoms in a healthy population: the HUNT study. Open Heart 2016; Feb 15: 3 (1).Gustad LT, Bjerkeset O, Strand LB, et al. Cardiac function associated with previous, current and repeated depression and anxiety symptoms in a healthy population: the HUNT study. Open Heart 2016; Feb 15: 3 (1).Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 2004; 18 (1): 37-48.Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 2004; 18 (1): 37-48.Smulevich AB, Andrushchenko AV, Romanov DV. Psychopharmacotherapy of borderline anxiety disorders (comparative study of the anxiolytic effect of afobazole and oxazepam in patients with adaptation disorders and generalized anxiety disorder). Rus Med J 2006; 14 (9): 725-9. Russian (Смулевич А.Б., Андрющенко А.В., Романов Д.В. Психофармакотерапия тревожных расстройств пограничного уровня (сравнительное исследование анксиолитического эффекта афобазола и оксазепама у больных с расстройствами адаптации и генерализованным тревожным расстройством). Русский медицинский ж 2006; 14 (9): 725-9).Smulevich AB, Andrushchenko AV, Romanov DV. Psychopharmacotherapy of borderline anxiety disorders (comparative study of the anxiolytic effect of afobazole and oxazepam in patients with adaptation disorders and generalized anxiety disorder). Rus Med J 2006; 14 (9): 725-9. Russian (Смулевич А.Б., Андрющенко А.В., Романов Д.В. Психофармакотерапия тревожных расстройств пограничного уровня (сравнительное исследование анксиолитического эффекта афобазола и оксазепама у больных с расстройствами адаптации и генерализованным тревожным расстройством). Русский медицинский ж 2006; 14 (9): 725-9).Bhattacharyya D, Jana U, Debnath PK, et al. Initial exploratory observational pharmacology of Valeriana wallichii on stress management: a clinical report. Nepal Med Coll J 2007; 9 (1): 36-9.Bhattacharyya D, Jana U, Debnath PK, et al. Initial exploratory observational pharmacology of Valeriana wallichii on stress management: a clinical report. Nepal Med Coll J 2007; 9 (1): 36-9.Cases J, Ibarra A, Feuillère N, et al. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Mediterranean Journal of Nutrition and Metabolism 2011; 4 (3): 211-8.Cases J, Ibarra A, Feuillère N, et al. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Mediterranean Journal of Nutrition and Metabolism 2011; 4 (3): 211-8.

The authors declare that there are no conflicts of interest present.